Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors—Results from the Swiss IBD Cohort Study

Sylvie Scharl, Christiane Barthel, Jean‐Benoît Rossel, Luc Biedermann, Benjamin Misselwitz, Alain Schoepfer, Alex Straumann, Stephan R. Vavricka, Gerhard Rogler, Michael Scharl,

The American Journal of Gastroenterology · 2018 · 67 citations · 29 references

Abstract

IBD patients showed increased risk for lymphoma and biliary cancer, but not colorectal cancer and cancer overall. Age and recent use of immunomodulators were the main risk factors for malignancy, while aminosalicylates and biologics appear to be protective.

References

29